Abstract
Biologic grafts may be a viable alternative to their prosthetic counterparts in the patients who have exhausted conventional access alternatives given their superior patency rates and possible resilience to infection. This is a case report of a 66-year-old woman with end-stage renal disease and human immunodeficiency virus who has had multiple failed peripheral arteriovenous (AV) fistulas and grafts as well as inferior vena caval obstruction necessitating a transhepatic catheter for hemodialysis (HD). Given the patient's comorbidities and history, a right brachial artery-to-atrial conduit was created for long-term access. Biologic bovine carotid artery was used given its decreased susceptibility to infection and favorable patency rates. The AV access continues to function at 3.5-year follow-up and remains her primary means of HD. We present this novel use of a biologic graft as an option in patients with central venous obstruction and high risk of infection requiring exotic dialysis access.
Original language | English (US) |
---|---|
Pages (from-to) | 1662.e13-1662.e18 |
Journal | Annals of Vascular Surgery |
Volume | 29 |
Issue number | 8 |
DOIs | |
State | Published - 2015 |
ASJC Scopus subject areas
- Surgery
- Cardiology and Cardiovascular Medicine